Nuveen Asset Management, LLC Alx Oncology Holdings Inc Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 105,894 shares of ALXO stock, worth $638,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,894

Previous 105,894 -0.0%

Holding current value

$638,540

Previous $1.58 Million 25.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $87,739 - $280,546	18,241 Added 20.81%	105,894 $1.58 Million
Q3 2023 Nov 14, 2023	SELL	$4.19 - $7.35 $43,622 - $76,520	-10,411 Reduced 10.62%	87,653 $420,000
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $31,644 - $81,981	-7,001 Reduced 6.66%	98,064 $443,000
Q4 2022 Feb 14, 2023	SELL	$9.51 - $12.95 $100,387 - $136,700	-10,556 Reduced 9.13%	105,065 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $9,859 - $18,137	-1,198 Reduced 1.03%	115,621 $1.11 Million

Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $401,656 - $1.33 Million	68,193 Added 140.24%	116,819 $945,000
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $207,889 - $335,973	-15,230 Reduced 23.85%	48,626 $872,000
Q4 2021 Feb 14, 2022	SELL	$21.49 - $74.4 $28,560 - $98,877	-1,329 Reduced 2.04%	63,856 $1.37 Million
Q3 2021 Nov 12, 2021	SELL	$52.51 - $80.91 $1.56 Million - $2.41 Million	-29,752 Reduced 31.34%	65,185 $4.81 Million
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $436,339 - $628,847	8,359 Added 9.65%	94,937 $5.19 Million
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $2.49 Million - $3.48 Million	39,673 Added 84.58%	86,578 $6.39 Million
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $375,107 - $1.23 Million	10,997 Added 30.63%	46,905 $4.04 Million
Q3 2020 Nov 16, 2020	BUY	$29.36 - $47.1 $1.05 Million - $1.69 Million	35,908 New	35,908 $1.36 Million

Others Institutions Holding ALXO

# of Institutions

115

Shares Held

38.4M

Call Options Held

132K

Put Options Held

19.7K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $246M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Alx Oncology Holdings Inc Transaction History